
Global Cord Blood Corporation CO
Annual report 2022
added 08-16-2022
Global Cord Blood Corporation Shares 2011-2025 | CO
Annual Shares Global Cord Blood Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 122 M | 122 M | 122 M | 121 M | 119 M | 73 M | 73 M | 73 M | 73 M | 71.5 M | 73.9 M | 70.1 M |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 122 M | 70.1 M | 92.7 M |
Quarterly Shares Global Cord Blood Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 122 M | - | 122 M | - | 122 M | - | 122 M | - | 122 M | - | 122 M | - | 122 M | - | 121 M | - | 121 M | - | 114 M | - | 73 M | - | 73 M | - | 73 M | - | 73 M | - | 73 M | - | 73 M | - | 73 M | - | 73 M | 73 M | 73 M | - | 69.9 M | 73.1 M | 73.1 M | 73.2 M | 74.5 M | - | 75.4 M |
All numbers in CNY currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 122 M | 69.9 M | 91.4 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M | ||
|
Brainsway Ltd.
BWAY
|
31.2 M | $ 16.75 | -1.28 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 16.9 | 7.3 % | $ 183 M | ||
|
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
1.27 M | $ 1.57 | -3.08 % | $ 2 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M | ||
|
Castle Biosciences
CSTL
|
27.8 M | $ 38.44 | -0.5 % | $ 1.07 B | ||
|
DarioHealth Corp.
DRIO
|
28.4 M | $ 12.0 | 0.93 % | $ 340 M | ||
|
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | ||
|
DexCom
DXCM
|
386 M | $ 66.39 | -0.85 % | $ 25.6 B | ||
|
Danaher Corporation
DHR
|
731 M | $ 226.5 | - | $ 166 B | ||
|
Exact Sciences Corporation
EXAS
|
185 M | $ 101.57 | 0.07 % | $ 18.8 B | ||
|
Fulgent Genetics
FLGT
|
30.2 M | $ 26.81 | -1.22 % | $ 811 M | ||
|
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
53.8 M | $ 19.74 | -3.99 % | $ 1.06 B | ||
|
Celcuity
CELC
|
39.4 M | $ 102.0 | -3.09 % | $ 4.02 B | ||
|
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
31.9 K | $ 3.53 | -1.4 % | $ 113 K | ||
|
Co-Diagnostics
CODX
|
29.3 M | $ 0.31 | -9.4 % | $ 9.1 M | ||
|
Quidel Corporation
QDEL
|
42.1 M | $ 28.81 | 0.03 % | $ 1.21 B | ||
|
IQVIA Holdings
IQV
|
181 M | $ 222.3 | 0.04 % | $ 40.3 B | ||
|
Guardant Health
GH
|
123 M | $ 103.47 | 1.37 % | $ 12.7 B | ||
|
Aspira Women's Health
AWH
|
117 M | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
159 M | $ 133.88 | -0.73 % | $ 21.3 B | ||
|
Charles River Laboratories International
CRL
|
51.4 M | $ 196.14 | 1.64 % | $ 10.1 B | ||
|
Quotient Limited
QTNT
|
91.6 M | - | -11.32 % | $ 1.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
111 M | $ 183.36 | 0.47 % | $ 20.4 B | ||
|
Biodesix
BDSX
|
130 M | $ 7.56 | -3.63 % | $ 980 M | ||
|
Mettler-Toledo International
MTD
|
21.2 M | $ 1 410.24 | 1.17 % | $ 29.9 B | ||
|
Laboratory Corporation of America Holdings
LH
|
83.9 M | $ 262.29 | -0.71 % | $ 22 B | ||
|
Myriad Genetics
MYGN
|
90.6 M | $ 7.01 | -2.84 % | $ 635 M | ||
|
ICON Public Limited Company
ICLR
|
82.5 M | $ 183.39 | -1.71 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
82.5 M | $ 701.16 | -0.43 % | $ 57.8 B | ||
|
Lantheus Holdings
LNTH
|
69.2 M | $ 67.34 | 1.08 % | $ 4.66 B | ||
|
NeoGenomics
NEO
|
127 M | $ 12.07 | 1.81 % | $ 1.53 B | ||
|
Neogen Corporation
NEOG
|
217 M | $ 6.8 | -0.95 % | $ 1.47 B | ||
|
Agilent Technologies
A
|
304 M | $ 140.63 | 0.69 % | $ 42.8 B | ||
|
Biomerica
BMRA
|
2.3 M | $ 2.56 | 0.29 % | $ 5.88 M | ||
|
Bioventus
BVS
|
62.6 M | $ 7.59 | 0.53 % | $ 475 M | ||
|
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M | ||
|
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K |